endo.digital is a vertical brand representing the platform developed by DreaMed Diabetes for over a decade.
The company was established by a group of doctors, scientists and engineers frustrated that expert medical knowledge is not globally accessible for all health professionals to use. Focusing initially on Diabetes, we are changing this status quo, one chronic condition at a time.
Eran brings over 13 years of experience in leading diabetes-related technology endeavors and has accrued expertise in clinical and business development, regulatory strategy, and investor relations. Beforehand, Eran was the R&D Director for the MD-Logic Artificial Pancreas Project at the Schneider Children’s Medical Center. Eran has a B.A. and M.Sc. in Bio-Medical Engineering from the Faculty of Engineering at Tel Aviv University (Cum Laude) and an MBA in Technology, Entrepreneurship, and Innovation from Tel Aviv University.
Prof. Philip is a world-renowned specialist in Pediatric Endocrinology. Professor Philip is currently the Director of the Institute for Endocrinology and Diabetes at the National Center for Childhood Diabetes of the Schneider Children’s Medical Center and Vice Dean for Research and Development at the Sackler Faculty of Medicine Tel-Aviv University. Prof. Philip has held many academic positions, published numerous research papers, and is considered one of the leading key opinion leaders in the international diabetes industry
Ryan has a thirteen-year record of accomplishment in leading growth strategies and business and product launches. He previously served at Optum Population Health solutions, part of the United Health Group, as V.P. of Provider Solutions. He launched a new portfolio of products and led strategies for new partnerships and acquisitions. Mr.Hovey holds an MBA from Stephen M. Ross School of Business at the University of Michigan and a B.A. from the University of San Diego.
Dr. Nimri is a senior pediatric endocrinologist and diabetes expert focusing on new and innovative technologies to treat type 1 diabetes, with vast experience in developing automated insulin delivery systems, the MD-Logic closed-loop system, and other decision support systems. Dr. Nimri also serves as Director of the Scientific and Technology Diabetes Service at The National Center for Childhood Diabetes at Schneider Children’s Medical Center of Israel. She has an M.D. from Technion - Faculty of Medicine, Haifa.
Eran has 16 years of experience in product management and development and software design, including leading roles in decision-support companies. Eran was V.P. Product at MediSafe, a company developing a medication management solution, Senior Product Manager at Healarium, which creates a digital health platform. Before that, Eran was a product manager at Kenshoo and Orca Interactive. Eran has a B.Sc. in Computer Science from the Academic College of Tel Aviv and an MBA in Management of Technology, Entrepreneurship, and Innovation from Tel Aviv University.
Yael has eleven years of experience managing clinical operation teams at CRO and medical device companies and as an academic researcher. M.S. Shtrit previously served as Clinical Department Manager and Data Management Department Manager at TechnoSTAT Ltd. Before that, Ms. Shtrit was a researcher at the Department of Neurology, Sheba Medical Center. MS. Shtrit holds a B.Sc. in Biology and an MSc in Epidemiology from Tel Aviv University, and an MBA in Healthcare Innovation from IDC Herzliya.
Ido has close to a decade of experience managing and developing AI-based technologies to produce drug treatment recommendations. Mr. Muller previously served as Clinical Operations Director of the Diabetes Technology Center of the National Center for Childhood Diabetes at Schneider Children’s Medical Center. Mr. Muller holds a B.Sc in Biomedical Engineering, AFEKA Tel- Aviv Academic College of Engineering, and an M.Sc Bio-Medical Engineering from Tel- Aviv University.
Inbal has over a decade of experience managing regulatory affairs, quality assurance, and clinical trials at leading medical device companies. Ms. Peled previously served as Director of R.A. & Q.A. at Nobio Litd, and as Regulatory Affairs Director at Lifebond Ltd., Ms. Peled holds a B.Sc. in biology from Tel Aviv University.
Prof. Philip is a world-renowned specialist in Pediatric Endocrinology. Professor Philip is currently the Director of the Institute for Endocrinology and Diabetes at the National Center for Childhood Diabetes of the Schneider Children’s Medical Center and Vice Dean for Research and Development at the Sackler Faculty of Medicine Tel-Aviv University. Prof. Philip has held many academic positions, published numerous research papers, and is considered one of the leading key opinion leaders in the international diabetes industry
Prof. Philip is a world-renowned specialist in Pediatric Endocrinology. Professor Philip is currently the Director of the Institute for Endocrinology and Diabetes at the National Center for Childhood Diabetes of the Schneider Children’s Medical Center and Vice Dean for Research and Development at the Sackler Faculty of Medicine Tel-Aviv University. Prof. Philip has held many academic positions, published numerous research papers, and is considered one of the leading key opinion leaders in the international diabetes industry
Prof. Philip is a world-renowned specialist in Pediatric Endocrinology. Professor Philip is currently the Director of the Institute for Endocrinology and Diabetes at the National Center for Childhood Diabetes of the Schneider Children’s Medical Center and Vice Dean for Research and Development at the Sackler Faculty of Medicine Tel-Aviv University. Prof. Philip has held many academic positions, published numerous research papers, and is considered one of the leading key opinion leaders in the international diabetes industry
Prof. Philip is a world-renowned specialist in Pediatric Endocrinology. Professor Philip is currently the Director of the Institute for Endocrinology and Diabetes at the National Center for Childhood Diabetes of the Schneider Children’s Medical Center and Vice Dean for Research and Development at the Sackler Faculty of Medicine Tel-Aviv University. Prof. Philip has held many academic positions, published numerous research papers, and is considered one of the leading key opinion leaders in the international diabetes industry
The company was established in 2014, commercializing the first artificial pancreas technology which was published in the NEJM. Ever since, DreaMed Diabetes has been vigorously working on decision support tools in the diabetes management space and has become the first and only company in the world to receive FDA clearance for a decision support system using data from CGM/SMBG and insulin pumps.
Our founders are all physicians and engineers. The products we develop are based on real insights from clinical practice of diabetes specialists, physicians, and clinical researchers from the top diabetes centers worldwide.
We give great importance to privacy, security, quality, and regulatory matters and operate under our strict quality management system and in compliance with ISO 27001, GDPR and HIPAA. Our product is FDA and CE cleared.
